Staphylococcus aureus is a virulent pathogen that is currently the most common cause of infections in hospitalized patients. S. aureus infection can involve any organ system. The success of S. aureus as a pathogen and its ability to cause such a wide range of infections are the result of its extensive virulence factors. The increase in the resistance of this virulent pathogen to antibacterial agents, coupled with its increasing prevalence as a nosocomial pathogen, is of major concern. The core resistance phenotype that seems to be most associated with the persistence of S. aureus in the hospital is methicillin resistance. Methicillin resistance in nosocomial S. aureus isolates has been increasing dramatically in United States hospitals and is also associated with resistance to other useful antistaphylococcal compounds. Possible ways to decrease the incidence of nosocomial S. aureus infections include instituting more effective infection control, decreasing nasal colonization, developing vaccines, and developing new or improved antimicrobials.
Staphylococcus aureus has been recognized as a major hutidrug-resistant S. aureus is not just a problem in the United States but is worldwide. man pathogen ever since Sir Alexander Ogston [1] first proposed, in the 1880s, that it was the major cause of wound Thus, S. aureus is a virulent pathogen that is currently the most common cause of infections in hospitalized patients. Its suppuration. Evidence for its virulence was shown in 1941, when Skinner and Keefer [2] reported that the mortality rate increasing resistance to antibiotics indicates that its prevalence will continue to rise. Given the number and severity of associated with S. aureus bacteremia in 122 patients at the Boston City Hospital was 82%. Furthermore, even though the S. aureus infections in the United States and in other countries, it is important to understand the nature and pathogenesis of introduction of b-lactam antibiotics into widespread clinical use markedly decreased mortality rates, 27% of patients with infections and the current strategies available for therapy and prevention. S. aureus bacteremia who were seen at the Johns Hopkins Hospital in the early 1960s died; these deaths occurred despite the fact that the patients' infecting organisms were susceptible in vitro to the antibiotics administered [3] .
Spectrum of Infections Currently, S. aureus is second only to coagulase-negative Those infections or syndromes that S. aureus can cause are staphylococci as a cause of hospital-acquired bacteremia and listed in table 1 (the diseases in boldface are those for which is the leading potentially lethal cause of these infections [4] .
S. aureus is the only or the most common pathogen). It is In addition, for 1990 to 1992, S. aureus was identified by evident that the organism can involve any organ system, and the National Nosocomial Infections Surveillance system as the the number of infections that it causes is matched by no other leading overall cause of hospital-acquired infections [4] . Fisingle pathogen. nally, the percentage of methicillin-resistant S. aureus (MRSA) in United States hospitals rose from 2.4% in 1975 to 29% in 1991, with a MRSA rate of 38% at large (ú200 beds) hospitals.
Pathogenesis of Infection Furthermore, the increase in the prevalence of MRSA and mulThe five stages in the pathogenesis of S. aureus infections are (1) colonization, (2) local infection, (3) systemic dissemination and/or sepsis, (4) metastatic infection, and (5) toxinosis. Specific factors are present that allow the organism to initially thwart opsonophagocytosis, walling off the infection to form an virulence factors are produced at specific times during growth abscess; to invade through tissue from the initial site of infection;
and in response to the local environment [8] . to induce the sepsis syndrome by promoting massive cytokine It is apparent that the control of infections caused by a release; to move out of the blood into underlying tissue by atpathogen as virulent as S. aureus is of major importance. The taching to and invading endothelial cells; and to produce specific increase in the resistance of this pathogen to antibacterial syndromes by toxin production. There are also specific global agents, coupled with its increasing prevalence as a nosocomial regulatory systems, such as agr and sar, that determine which pathogen, is of major concern. 
